Sarcomas and related proliferative lesions of specialized prostatic stroma: A clinicopathologic study of 22 cases

American Journal of Surgical Pathology

Volumn 22, Issue 2, 1998, Pages 148-162

  Gaudin, Paul B ^a   Rosai, Juan ^a   Epstein, Jonathan I ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

CD34; Cystosarcoma phyllodes; Immunohistochemistry; Phyllodes tumor; Prostate; Sarcoma; Stromal hyperplasia; Stromal neoplasms

Indexed keywords

CD34 ANTIGEN;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CYSTOSARCOMA PHYLLOIDES; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; SARCOMA; STROMA CELL; TUMOR DIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CELL DIVISION; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SARCOMA; STROMAL CELLS;

EID: 0031891449     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199802000-00002     Document Type: Article

References (57)

1. Attah EB, Nkposong EO. Phyllodes type of atypical prostatic hyperplasia. J Urol 1976;115:762-764.
2. Attah EB, Powell ME. Atypical stromal hyperplasia of the prostate gland. Am J Clin Pathol 1977;67:324-7.
3. Bierhoff E, Vogel J, Benz M, Giefer T, Wernert N, Pfeifer U. Stromal nodules in benign prostatic hyperplasia. Eur Urol 1996; 29:345-54.
4. Bos SD, Slaa ET. An adult man with a rhabdomyosarcoma of the prostate. A case report. Scand J Urol Nephrol 1991;25:329-30.
5. Brolin J, Skoog L, Ekman P. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate 1992;20: 281-95.
6. Byrne RL, Leung H, Neal DE. Peptide growth factors in the prostate as mediators of stromal epithelial interaction. Br J Urol 1996; 77:627-33.
7. Cartun RW, Pedersen CA. An immunocytochemical technique offering increased sensitivity and lowered cost with a streptavidinhorseradish peroxidase conjugate. J Histotechnol 1989;12:273-77.
8. Chung LW, Cunha GR. Stromal-epithelial interactions: II. Regulation of prostatic growth by embryonic urogenital sinus mesenchyme. Prostate 1983;4:503-11.
9. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984;133:157-65.
10. Clement PB, Scully RE. Mullerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of müllerian mixed tumor. Cancer 1974;34:1138-49.
11. Clement PB, Scully RE. Extrauterine mesodermal (müllerian) adenosarcoma: a clinicopathologic analysis of five cases. Am J Clin Pathol 1978;69:276-83.
12. Cox R, Dawson IMP. A curious prostatic tumor: probably a true mixed tumor (cystadeno-leiomyofibroma). Br J Urol 1960;32: 306-11.
13. Cummine HG, Johnson AS. Report of a case of retrovesicle polycystic tumor of probable prostatic origin. Aust N Z J Surg 1950; 19:91-2.
14. Cunha GR. Epithelial-stromal interactions in development of the urogenital tract. Int Rev Cytol 1976;47:137-94.
15. Cunha GR. Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 1994;74:1030-44.
16. Cunha GR, Donjacour A. Stromal-epithelial interactions in normal and abnormal prostatic development. Prog Clin Biol Res 1987; 239:251-72.
17. Cunha GR, Donjacour AA, Cooke PS, et al. The endocrinology and developmental biology of the prostate. Endocr Rev 1987;8: 338-62.
18. Donjacour AA, Cunha GR. Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice. Endocrinology 1993;132:2342-50.
19. Fain JS, Cosnow I, King BF, Zincke H, Bostwick DG. Cystosarcoma phyllodes of the seminal vesicle. Cancer 1993;71:2055-61.
20. Fina L, Molgaard HV, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood 1990;75:2417-26.
21. Grimes MM. Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations. Mod Pathol 1992;5:232-9.
22. Gueft B, Walsh MA. Malignant prostatic cystosarcoma phyllodes. N Y State J Med 1975;75:2226-8.
23. Hiramatsu M, Maehara I, Orikasa S, Sasano H. Immunolocalization of oestrogen and progesterone receptors in prostatic hyperplasia and carcinoma. Histopathology 1996;28:163-8.
24. Huang WL, Ro JY, Grignon DJ, Swanson D, Ordóñez NG, Ayala AG. Postoperative spindle cell nodule of the prostate and bladder. J Urol 1990;143:824-6.
25. Ito H, Ito M, Mitsuhata N, Tahara E. Phyllodes tumor of the prostate: a case report. Jpn J Clin Oncol 1989;19:299-304.
26. Kendall AR, Stein BS, Shea FJ, Petersen RO, Senay B. Cystic pelvic mass. J Urol 1986;135:550-3.
27. Kerley SW, Pierce P, Thomas J. Giant cystosarcoma phyllodes of the prostate associated with adenocarcinoma. Arch Pathol Lab Med 1992;116:195-7.
28. Kevwitch MK, Walloch JL, Waters WB, Flanigan RC. Prostatic cystic epithelial-stromal tumors: a report of 2 new cases. J Urol 1993;149:860-4.
29. Laurila P, Leivo I, Makisalo H, Ruutu M, Miettinen M. müllerian adenosarcomalike tumor of the seminal vesicle. A case report with immunohistochemical and ultrastructural observations. Arch Pathol Lab Med 1992;116:1072-6.
30. Lauwers GY, Schevchuk M, Armenakas N, Reuter VE. Carcinosarcoma of the prostate. Am J Surg Pathol 1993;17:342-9.
31. Leong SS, Vogt PJ, Yu GSM. Atypical stromal smooth muscle hyperplasia of prostate. Urology 1988;31:163-7.
32. Lindenmayer AE, Miettinen M. Immunophenotypic features of uterine stromal cells. CD34 expression in endocervical stroma. Virchows Arch 1995;426:457-60.
33. Lopez-Beltran A, Gaeta JF, Huben R, Croghan GA. Malignant phyllodes tumor of prostate. Urology 1990;35:164-7.
34. Manivel C, Shenoy BV, Wick MR, Dehner LP. Cystosarcoma phyllodes of the prostate. A pathologic and immunohistochemical study. Arch Pathol Lab Med 1986;110:534-8.
35. Mazur MT, Myers JL, Maddox WA. Cystic epithelial-stromal tumor of the seminal vesicle. Am J Surg Pathol 1987;11:210-7.
36. McDivitt RW, Urban JA, Farrow JH. Cystosarcoma phyllodes. Johns Hopkins Med J 1967;120:33-45.
37. Michel F, Gattegno B, Roland J, Coloby P, Colbert N, Thibault P. Primary nonseminomatous germ cell tumor of the prostate. J Urol 1986;135:597-9.
38. Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994;7:82-90.
39. Neubauer BL, Chung LW, McCormick KA, Taguchi O, Thompson TC, Cunha GR. Epithelial-mesenchymal interactions in prostatic development. II. Biochemical observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. J Cell Biol 1983;96:1671-6.
40. Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer 1967;20:2090-9.
41. Proppe KH, Scully RE, Rosai J. Postoperative spindle cell nodules of genitourinary tract resembling sarcomas. A report of eight cases. Am J Surg Pathol 1984;8:101-8.
42. Rao BR, Meyer JS, Fry CG. Most cystosarcoma phyllodes and fibroadenomas have progesterone receptor but lack estrogen receptor: stromal localization of progesterone receptor. Cancer 1981; 47:2016-21.
43. Reese JH, Lombard CM, Krone K, Stamey TA. Phyllodes type of atypical prostatic hyperplasia: a report of 3 new cases. J Urol 1987;138:623-6.
44. Ro JY, el-Naggar AK, Amin MB, Sahin AA, Ordóñez NG, Ayala AG. Pseudosarcomatous fibromyxoid tumor of the urinary bladder and prostate: immunohistochemical, ultrastructural, and DNA flow cytometric analyses of nine cases. Hum Pathol 1993;24:1203-10.
45. Russo P, Brady MS, Conlon K, et al. Adult urological sarcoma. J Urol 1992;147:1032-7.
46. Shannon RL, Ro JY, Grignon DJ, et al. Sarcomatoid carcinoma of the prostate. A clinicopathologic study of 12 patients. Cancer 1992;69:2676-82.
47. Sugimura Y, Cunha GR, Bigsby RM. Androgenic induction of DNA synthesis in prostatic glands induced in the urothelium of testicular feminized (Tfm/Y) mice. Prostate 1986;9:217-25.
48. Tetu B, Ro JY, Ayala AG, Srigley JR, Begin LR, Bostwick DG. Atypical spindle cell lesions of the prostate. Semin Diagn Pathol 1988;5:284-93.
49. Traweek ST, Kandalaft PL, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol 1991;96:25-31.
50. Treves N. A study of cystosarcoma phyllodes. Ann N Y Acad Sci 1964;114:922-36.
51. van de Rijn M, Hendrickson MR, Rouse RV. CD34 expression by gastrointestinal tract stromal tumors. Hum Pathol 1994;25:766-71.
52. Waring PM, Newland RC. Prostatic embryonal rhabdomyosarcoma in adults. A clinicopathologic review. Cancer 1992;69:755-62.
53. Westra WH, Gerald WL, Rosai J. Solitary fibrous tumor. Consistent CD34 immunoreactivity and occurrence in the orbit. Am J Surg Pathol 1994;18:992-8.
54. Yokota T, Yamashita Y, Okuzono Y, et al. Malignant cystosarcoma phyllodes of prostate. Acta Pathol Jpn 1984;34:663-8.
55. Young JF, Jensen PE, Wiley CA. Malignant phyllodes tumor of the prostate. A case report with immunohistochemical and ultrastructural studies. Arch Pathol Lab Med 1992;116:296-9.
56. Young RH and Scully RE. Pseudosarcomatous lesions of the urinary bladder, prostate gland, and urethra. Arch Pathol Lab Med 1987;111:354-8.
57. Yum M, Miller JC, Agrawal BL. Leiomyosarcoma arising in atypical fibromuscular hyperplasia (phyllodes tumor) of the prostate with distant metastasis. Cancer 1991;68:910-5.